Herpes simplex virus encephalitis: New infection or reactivation?

Current Opinion in Neurology

Volumn 24, Issue 3, 2011, Pages 268-274

  Steiner, Israel ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

encephalitis; herpes simplex virus; latent infection; reactivation; therapy

Indexed keywords

ACICLOVIR; CIDOFOVIR; CORTICOSTEROID; DEXAMETHASONE; PROBENECID;

ANTIVIRAL ACTIVITY; ARTICLE; ASEPTIC MENINGITIS; CLINICAL FEATURE; DISEASE CARRIER; DRUG HALF LIFE; EARLY DIAGNOSIS; GENE EXPRESSION; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; LATENT VIRUS INFECTION; MORBIDITY; MORTALITY; NEPHROTOXICITY; NEWBORN DISEASE; NONHUMAN; PATHOGENESIS; PRIMARY INFECTION; PROGNOSIS; RECURRENT DISEASE; SPINAL GANGLION; VIRUS REACTIVATION;

ANIMALS; ANTIVIRAL AGENTS; ENCEPHALITIS, HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; PROGNOSIS; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 79955627508     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328346be6f     Document Type: Article

References (83)

1. Roizman B, Whitley RJ. The nine ages of herpes simplex virus. Herpes 2001; 8:23-27. (Pubitemid 32290375)
2. Cumston CG. The history of herpes from the earliest times to the nineteenth century. Ann Med Hist 1926; 8:284-291.
3. Astruc J. De Morbis Venereis Libri Sex. Paris: G Cavelier; 1736.
4. Today's Scarlet Letter, Herpes. TIME 2 August 1982.
5. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and-sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 1990; 69:19-36. (Pubitemid 20333084)
6. Nilsen A, Myremel H. Changing trends in genital herpes simplex virus infection in Bergen, Norway. Acta Obstet Gynecol Scand 2000; 79:693-696. (Pubitemid 30487556)
7. Tran T, Druce JD, Catton MC, et al. Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003. Sex Transm Infect 2004; 80:277-279. (Pubitemid 39070788)
8. Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003; 30:797-800. (Pubitemid 37229492)
9. Buxbaum S, Geers M, Gross G, et al. Epidemiology of herpes simplex virus types 1 and 2 in Germany: what has changed? Med Microbiol Immunol (Berl) 2003; 192:177-181. (Pubitemid 37100665)
10. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002; 186 (Suppl 1): S3-S28. (Pubitemid 35178845)
11. Steiner I, Kennedy PGE. Herpes simplex virus type 1 latent infection in the nervous system. J Neurovirol 1995; 1:19-29.
12. Goodpasture EW. Herpetic infections with special reference to involvement of the nervous system. Medicine 1929; 8:223-243.
13. Hope-Simpson RE. The nature of herpes zoster: a long term study and a new hypothesis. Proc Roy Soc Med 1965; 58:9-20.
14. Steiner I, Spivack JG, Deshmane SL, et al. A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia. J Virol 1990; 64:1630-1638. (Pubitemid 20104900)
15. Steiner I, Kennedy PG. Herpes simplex virus latency in the nervous system: a new model. Neuropathol Appl Neurobiol 1991; 17:433-440.
16. Rock DL, Fraser NW. Detection of HSV-1 genome in the central nervous system of latently infected mice. Nature 1983; 302:523-525. (Pubitemid 13111134)
17. Steiner I, Spivack JG, O'Boyle DR, et al. Latent herpes virus type 1 transcription in human trigeminal ganglia. J Virol 1988; 62:3493-3496.
18. Goldenberg D, Mador N, Ball MJ, et al. The abundant latency-associated transcripts of herpes simplex virus type 1 are bound to polyribosomes in cultured neuronal cells and during latent infection in mouse trigeminal ganglia. J Virol 1997; 71:2897-2904. (Pubitemid 27119931)
19. Steiner I, Spivack JG, Lirette RP, et al. Herpes simplex virus type 1 latencyassociated transcripts are evidently not essential for latent infection. EMBO J 1989; 8:505-511. (Pubitemid 19274970)
20. Perng GC, Jones C. Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle. Interdiscip Perspect Infect Dis 2010; 2010:262415. An up-to-date review on HSV-1 molecular biology of latency and reactivation.
21. Shen W, Sa e Silva M, Jaber T, et al. Two small RNAs encoded within the first 1.5 kilobases of the herpes simplex virus type 1 latency-associated transcript can inhibit productive infection and cooperate to inhibit apoptosis. J Virol 2009; 83:9131-9139.
22. Tang S, Bertke AS, Patel A, et al. Herpes Simplex Virus-2 miR-H6 is a novel LAT-associated microRNA, but reduction of its expression does not influence viral latency establishment or recurrence phenotype. J Virol 2011 [Epub ahead of print].
23. Krause PR, Stanberry LR, Bourne N, et al. Expression of the herpes simplex virus type 2 latency-associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs. J Exp Med 1995; 181:297-306.
24. Knaup B, Schunemann S, Wolff MH. Subclinical reactivation of herpes simplex virus type 1 in the oral cavity. Oral Microbiol Immunol 2000; 15:281-283.
25. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type .2. infection in asymptomatic seropositive persons. N Engl J Med 2000; 342:844-850. (Pubitemid 30165207)
26. Whitley RJ. Herpes simplex virus. In: Scheld WM, Whitley RJ, Durack DT, editors. Infections of the central nervous system. 2nd ed. Philadelphia: Lippincott-Raven; 1997. pp. 73-89.
27. Whitley RJ. Herpes simplex virus infections of the central nervous system. Encephalitis and neonatal herpes. Drugs 1991; 42:406-427. (Pubitemid 21920770)
28. Granerod J, Ambrose HE, Davies NW, et al., UK Health Protection Agency (HPA) Aetiology of Encephalitis Study Group. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, populationbased prospective study. Lancet Infect Dis 2010; 10:835-844.
29. Koskiniemi M, Piiparinen H, Mannonen L, et al. Herpes encephalitis is a disease of middle aged and elderly people: polymerase chain reaction for detection of herpes simplex virus in the CSF of 516 patients with encephalitis. The Study Group. J Neurol Neurosurg Psychiatry 1996; 60:174-178. (Pubitemid 26044190)
30. Aurelius E, Johansson B, Skoldenberg B, Forsgren M. Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid. J Med Virol 1993; 39:179-186. (Pubitemid 23085127)
31. Davis LE, Johnson RT. An explanation for the localization of herpes simplex encephalitis? Ann Neurol 1979; 5:2-5. (Pubitemid 9083246)
32. Fraser NW, Lawrence WC, Wroblewska Z, et al. Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci USA 1981; 78:6461-6465. (Pubitemid 12179732)
33. Whitley R, Lakeman AD, Nahmias A, Roizman B. DNA restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med 1982; 307:1060-1062. (Pubitemid 12027064)
34. Whitley RJ. Herpes simplex virus. In: Scheld MW, Whitley RJ, Marra CM, editors. Infections in the central nervous system. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. pp. 123-144.
35. Mador N, Panet A, Steiner I. The latency-associated gene of herpes simplex virus type 1 (HSV-1) interferes with superinfection by HSV-1. J Neurovirol 2002; 8 (Suppl 2):97-102. (Pubitemid 36097784)
36. Hirai R, Ayabe M, Shoji H, et al. Herpes simplex encephalitis presenting with bilateral hippocampal lesions on magnetic resonance imaging, simultaneously complicated by small cell lung carcinoma. Intern Med 2005; 44:1006-1008. (Pubitemid 41644107)
37. Baskin HJ, Hedlund G. Neuroimaging of herpesvirus infections in children. Pediatr Radiol 2007; 37:949-963. (Pubitemid 47423290)
38. Stroop WG, Schaefer DC. Production of encephalitis restricted to the temporal lobes by experimental reactivation of herpes simplex virus. J Infect Dis 1986; 153:721-731. (Pubitemid 16133754)
39. Twomey JA, Barker CM, Robinson G, Howell DA. Olfactory mucosa in herpes simplex encephalitis. J Neurol Neurosurg Psychiatry 1979; 42:983-987. (Pubitemid 10236377)
40. Kumaravelu S, Duraiswamy R, Kalghatgi AT, Dhand VP. Atypical presentation of herpes simplex encephalitis in acquired immune deficiency syndrome. J Assoc Physicians India 1998; 46:316-317. (Pubitemid 128545073)
41. Ejima M, Tanaka H, Ueda M, et al. A case of chronic herpes encephalitis with myelodysplastic syndrome (MDS). Rinsho Shinkeigaku 1994; 34:246-249. (Pubitemid 24207810)
42. Darville JM, Ley BE, Roome AP, Foot AB. Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population. Bone Marrow Transplant 1998; 22:587-589. (Pubitemid 28445761)
43. Kennedy PGE. Viral encephalitis: causes, differential diagnosis and management. J Neurol Neurosurg Psychiatry 2004; 75 (Suppl):i10-i15.
44. Casrouge A, Zhang SY, Eidenschenk C, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006; 314:308-312. (Pubitemid 44571977)
45. Oldstone MB. Molecular anatomy of viral persistence. J Virol 1991; 65:6381-6386.
46. Hill A, Jugovic P, York I, et al. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995; 375:411-415.
47. Fruh K, Ahn K, Djaballah H, et al. A viral inhibitor of peptide transporters for antigen presentation. Nature 1995; 375:415-418.
48. Chou J, Kern ER, Whitley RJ, Roizman B. Mapping of herpes simplex virus-1 neurovirulence to g134.5, a gene nonessential for growth in culture. Science 1990; 250:1262-1266. (Pubitemid 120031840)
49. Harrow S, Papanastassiou V, Harland J, et al. HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival. Gene Ther 2004; 11:1648-1658. (Pubitemid 39530101)
50. Orvedahl A, Alexander D, Talloczy Z, et al. HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe 2007; 1:23-35. (Pubitemid 46506007)
51. Conrady CD, Drevets DA, Carr DJ. Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing? J Neuroimmunol 2010; 220:1-9.
52. Domingues RB, Tsanaclis AM, Pannuti CS, et al. Evaluation of the range of clinical presentations of herpes simplex encephalitis by using polymerase chain reaction assay of cerebrospinal fluid samples. Clin Infect Dis 1997; 25:86-91. (Pubitemid 27293080)
53. Studahl M, Bergstrom T, Hagberg L. Acute viral encephalitis in adults: a prospective study. Scand J Infect Dis 1998; 30:215-220. (Pubitemid 28461587)
54. Fodor PA, Levin MJ, Weinberg A, et al. Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology 1998; 51:554-559. (Pubitemid 28406337)
55. Grover D, Newsholme W, Brink N, et al. Herpes simplex virus infection of the central nervous system in human immunodeficiency virus-type 1-infected patients. Int J STD AIDS 2004; 15:597-600. (Pubitemid 39265553)
56. Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001; 345:1727-1733.
57. Sawyer J, Ellner J, Ransohoff DF. To biopsy or not to biopsy in suspected herpes simplex encephalitis: a quantitative analysis. Med Decis Making 1988; 8:95-101.
58. Lakeman FD, Whitley RJ, National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brainbiopsied patients and correlation with disease. J Infect Dis 1995; 171:857-863.
59. Davis LE, Tyler KL. Molecular diagnosis of CNS viral infections. J Neurol Neurosurg Psychiatry 2005; 76:1-4.
60. Dutt MK, Johnston ID. Computed tomography and EEG in herpes simplex encephalitis. Their value in diagnosis and prognosis. Arch Neurol 1982; 39:99-102. (Pubitemid 12222028)
61. Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 1986; 314:144-149. (Pubitemid 16183170)
62. James SH, Kimberlin DW, Whitley RJ. Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Res 2009; 83:207-213.
63. Steiner I, Budka H, Chaudhuri A, et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 2010; 17:999-1057.
64. VanLandigham KE, Marsteller HB, Ross GW, Hayden FG. Relapse of herpes simplex encephalitis after conventional acyclovir therapy. JAMA 1988; 259:1051-1053. (Pubitemid 18046856)
65. Cinque P, Cleator GM, Weber T, et al. The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis. J Neurol Neurosurg Psychiatry 1996; 61:339-345. (Pubitemid 26355772)
66. Ito Y, Kimura H, Yabuta Y, et al. Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir. Clin Infect Dis 2000; 30:185-187. (Pubitemid 30067080)
67. Chen Y, Scieux C, Garrait V, et al. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. Clin Infect Dis 2000; 31:927-935. (Pubitemid 32299349)
68. Safrin S, Crumpacker C, Chatis P, et al. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med 1991; 325:551-555.
69. Cundy KC. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet 1999; 36:127-143. (Pubitemid 29121686)
70. Naesens L, De Clercq E. Recent developments in herpesvirus therapy. Herpes 2001; 8:12-16. (Pubitemid 32290373)
71. Fitch MT, van de Beek D. Drug insight: steroids in CNS infectious diseases-new indications for an old therapy. Nat Clin Pract Neurol 2008; 4:97-104. (Pubitemid 351248067)
72. Hacke W. German trial of acyclovir and corticosteroids in herpes-simplexvirus-encephalitis (GACHE). 2006. ISRCTN Register. http://www.controlledtrials. com/ISRCTN45122933 [Accessed 29 March 2011].
73. McGrath N, Anderson NE, Croxson MC, Powell KF. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry 1997; 63:321-326. (Pubitemid 27412373)
74. Gordon B, Selnes OA, Hart J Jr, et al. Long-term cognitive sequelae of acyclovir-treated herpes simplex encephalitis. Arch Neurol 1990; 47:646-647. (Pubitemid 20183572)
75. Kimberlin DW. Management of HSV encephalitis in adults and neonates: diagnosis, prognosis and treatment. Herpes 2007; 14:11-16. (Pubitemid 47235458)
76. Whitley R, Arvin A, Prober C, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991; 324:450-454.
77. Overall JC Jr. Herpes simplex virus infection of the fetus and newborn. Pediatr Ann 1994; 23:131-136.
78. Mollaret P. La meningite endothelio-nucleocytaire multirecurrente benigne: syndrome nouveau ou maladie nouvelle? Rev Neurol 1944; 76:57-76.
79. Tyler KL, Adler D. Twenty-eight years of benign recurring Mollaret meningitis. Arch Neurol 1983; 40:42-43. (Pubitemid 13162916)
80. Berger JR. Benign aseptic (Mollaret's) meningitis after genital herpes. Lancet 1991; 337:1360-1361.
81. Picard FJ, Dekaban GA, Silva J, Rice GP. Mollaret's meningitis associated with herpes simplex type 2 infection. Neurology 1993; 43:1722-1727. (Pubitemid 23307944)
82. Yamamoto LJ, Tedder DG, Ashley R, Levin MJ. Herpes simplex virus type 1 DNA in cerebrospinal fluid of a patient with Mollaret's meningitis. N Engl J Med 1991; 325:1082-1085.
83. Berger JR, Houff S. Neurological complications of herpes simplex virus type 2 infection. Arch Neurol 2008; 65:596-600. (Pubitemid 351679652)